P

PeterLabs Holdings Bhd
KLSE:PLABS

Watchlist Manager
PeterLabs Holdings Bhd
KLSE:PLABS
Watchlist
Price: 0.2 MYR Market Closed
Market Cap: 103.2m MYR
Have any thoughts about
PeterLabs Holdings Bhd?
Write Note

PeterLabs Holdings Bhd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PeterLabs Holdings Bhd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
P
PeterLabs Holdings Bhd
KLSE:PLABS
Interest Income Expense
-myr794k
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
-14%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Interest Income Expense
myr13.1m
CAGR 3-Years
43%
CAGR 5-Years
12%
CAGR 10-Years
42%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Interest Income Expense
-myr1.5m
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Interest Income Expense
-myr890k
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
-16%
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Interest Income Expense
-myr20.2m
CAGR 3-Years
-50%
CAGR 5-Years
-20%
CAGR 10-Years
-59%
K
Kotra Industries Bhd
KLSE:KOTRA
Interest Income Expense
-myr26k
CAGR 3-Years
68%
CAGR 5-Years
59%
CAGR 10-Years
44%
No Stocks Found

PeterLabs Holdings Bhd
Glance View

Market Cap
103.2m MYR
Industry
Pharmaceuticals

PeterLabs Holdings Bhd.is an investment company, which engages in the manufacture, distribution and trading of animal health and nutrition products. The company is headquartered in Nilai, Negeri Sembilan. The company went IPO on 2011-07-26. The firm is engaged in the manufacturing, distribution and trading of animal health and nutrition products. Its segments include Manufacturing and Trading. The Manufacturing segment is engaged in the manufacturing of animal health and nutrition products. The Trading segment is engaged in the trading and distribution of animal health and nutrition products. Its products include biosecurity and disinfectant, compound feed supplement, feed additives, nutritional premix, pharmaceutical and water-soluble supplement. The firm provides technical information exchange with its customer’s supervisors, technicians and in-house veterinarians, livestock information sharing, post-mortem on diseased animals, blood sampling of diseased animals for testing and individualize latest technologies in the manufacture of feed additives for feed and farming industry.

PLABS Intrinsic Value
0.19 MYR
Overvaluation 5%
Intrinsic Value
Price
P

See Also

What is PeterLabs Holdings Bhd's Interest Income Expense?
Interest Income Expense
-794k MYR

Based on the financial report for Sep 30, 2024, PeterLabs Holdings Bhd's Interest Income Expense amounts to -794k MYR.

What is PeterLabs Holdings Bhd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-14%

Over the last year, the Interest Income Expense growth was -7%. The average annual Interest Income Expense growth rates for PeterLabs Holdings Bhd have been -2% over the past three years , -7% over the past five years , and -14% over the past ten years .

Back to Top